Therapeuticsmd Inc (TXMD)

Apr 24, 2025

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 24, 2025

Apr 23, 2025

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 23, 2025

Apr 23, 2025

TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World

Apr 23, 2025

Apr 21, 2025

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 21, 2025

Apr 20, 2025

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com - Defense World

Apr 20, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker acquires $489 in common stock By Investing.com - Investing.com Canada

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD director Tommy Thompson acquires $325 in stock - Investing.com Australia

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD director Tommy Thompson acquires $325 in stock By Investing.com - Investing.com Canada

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker acquires $489 in common stock - Investing.com

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker buys $489 in common stock By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

TherapeuticsMD CEO Marlan Walker buys $489 in common stock - Investing.com

Apr 15, 2025

Apr 12, 2025

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World

Apr 12, 2025

Apr 11, 2025

INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 11, 2025

Apr 11, 2025

DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 11, 2025

Apr 10, 2025

Mayne Pharma Faces Legal Challenge from TherapeuticsMD - TipRanks

Apr 10, 2025

Apr 10, 2025

TherapeuticsMD CEO Marlan Walker buys $1,994 in stock - Investing.com Australia

Apr 10, 2025

Apr 10, 2025

TherapeuticsMD CEO Marlan Walker buys $1,994 in stock By Investing.com - Investing.com India

Apr 10, 2025

Apr 09, 2025

TherapeuticsMD Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 09, 2025

Apr 09, 2025

TherapeuticsmdFiles Lawsuit Against Mayne Pharma For Breach Of Contract - marketscreener.com

Apr 09, 2025

Apr 04, 2025

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 04, 2025

Apr 03, 2025

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 03, 2025

Apr 02, 2025

TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com - Defense World

Apr 02, 2025

Mar 31, 2025

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 31, 2025

Mar 29, 2025

TherapeuticsMD Full Year 2024 Earnings: US$0.20 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance

Mar 29, 2025

Mar 29, 2025

TherapeuticsMD Reports Improved Financial Performance - TipRanks

Mar 29, 2025

Mar 27, 2025

DEADLINE MONDAY: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 -- TXMD - ACCESS Newswire

Mar 27, 2025

Mar 27, 2025

TherapeuticsMD Inc. (TXMD) reports earnings - Quartz

Mar 27, 2025

Mar 27, 2025

TherapeuticsMD Reports Reduced Losses and Revenue Growth - TipRanks

Mar 27, 2025

Mar 27, 2025

TherapeuticsMD Announces Full Year 2024 Financial Results - Business Wire

Mar 27, 2025